BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19796195)

  • 1. Gadoteridol-induced anaphylaxis - not a class allergy.
    Galera C; Pur Ozygit L; Cavigioli S; Bousquet PJ; Demoly P
    Allergy; 2010 Jan; 65(1):132-4. PubMed ID: 19796195
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal Anaphylaxis Associated With the Gadolinium-Based Contrast Agent Gadoteridol (ProHance).
    Takahashi S; Takada A; Saito K; Hara M; Yoneyama K; Nakanishi H
    J Investig Allergol Clin Immunol; 2015; 25(5):366-7. PubMed ID: 26727767
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrogenic systemic fibrosis in Japan: advisability of keeping the administered dose as low as possible.
    Tsushima Y; Takahashi-Taketomi A; Endo K
    Radiology; 2008 Jun; 247(3):915-6. PubMed ID: 18487548
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update.
    Kanal E; Broome DR; Martin DR; Thomsen HS
    Radiology; 2008 Jan; 246(1):11-4. PubMed ID: 17855656
    [No Abstract]   [Full Text] [Related]  

  • 5. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
    Witte RJ; Anzai LL
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe anaphylactoid shock secondary to gadolinium contrast media.
    Simons CW; Benouni S; Gibbon G; Klaustermeyer W
    Ann Allergy Asthma Immunol; 2009 Oct; 103(4):359-60. PubMed ID: 19852205
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaphylactic shock induced by gadoterate meglumine (DOTAREM).
    Beaudouin E; Kanny G; Blanloeil Y; Guilloux L; Renaudin JM; Moneret-Vautrin DA
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):382-5. PubMed ID: 14768523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal reaction to gadopentetate dimeglumine.
    Jordan RM; Mintz RD
    AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of immediate gadolinium contrast media reactions.
    Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Grenelle of MR contrast agents?].
    Clément O
    J Radiol; 2007 Nov; 88(11 Pt 1):1663. PubMed ID: 18065924
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 12. Anaphylactic shock induced by intravenous gadopentetate dimeglumine.
    Tardy B; Guy C; Barral G; Page Y; Ollagnier M; Bertrand JC
    Lancet; 1992 Feb; 339(8791):494. PubMed ID: 1346846
    [No Abstract]   [Full Text] [Related]  

  • 13. Anaphylaxis to trometamol excipient in gadolinium-based contrast agents for clinical imaging.
    Lukawska J; Mandaliya D; Chan AWE; Foggitt A; Bidder T; Harvey J; Stycharczuk L; Bisdas S
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1086-1087. PubMed ID: 30217530
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse reaction to intravenous gadoteridol.
    Shellock FG; Hahn HP; Mink JH; Itskovich E
    Radiology; 1993 Oct; 189(1):151-2. PubMed ID: 8372186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylactic shock after first exposure to a macrocyclic gadolinium chelate: a few comments.
    Idée JM; Corot C
    J Allergy Clin Immunol; 2008 Jul; 122(1):215-6; author reply 216-7. PubMed ID: 18547628
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)].
    Heuck A; Reiser M
    Internist (Berl); 1997 Dec; 38(12):1234-5. PubMed ID: 9465330
    [No Abstract]   [Full Text] [Related]  

  • 17. Life-threatening anaphylactoid reaction after iv injection of gadoterate meglumine.
    Meuli RA; Maeder P
    AJR Am J Roentgenol; 1996 Mar; 166(3):729. PubMed ID: 8623674
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.
    Soulez G; Bloomgarden DC; Rofsky NM; Smith MP; Abujudeh HH; Morgan DE; Lichtenstein RJ; Schiebler ML; Wippold FJ; Russo C; Kuhn MJ; Mennitt KW; Maki JH; Stolpen A; Liou J; Semelka RC; Kirchin MA; Shen N; Pirovano G; Spinazzi A
    AJR Am J Roentgenol; 2015 Sep; 205(3):469-78. PubMed ID: 26295633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal anaphylaxis caused by gadolinium due to beta-tryptase-induced hemorragic diathesis.
    Prieto-García A; Pérez-David E; Devesa C; Tornero P; Schwartz LB; Pascual C; Castells MC
    J Allergy Clin Immunol Pract; 2017; 5(5):1433-1434. PubMed ID: 28634099
    [No Abstract]   [Full Text] [Related]  

  • 20. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
    Tishler S; Hoffman JC
    AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.